SEARCH

SEARCH BY CITATION

References

  • Abi-Dargham A., Laruelle M., Aghajanian G. K., Charney D. and Krystal J. (1997) The role of serotonin in the pathophysiology and treatment of schizophrenia. J. Neuropsychiatry Clin. Neurosci. 9, 117.
  • Alonso M., Vianna M. R., Depino A. M. et al. (2002) BDNF-triggered events in the rat hippocampus are required for both short- and long-term memory formation. Hippocampus 12, 551560.
  • Antion M. D., Hou L., Wong H., Hoeffer C. A. and Klann E. (2008a) mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice. Mol. Cell. Biol. 28, 29963007.
  • Antion M. D., Merhav M., Hoeffer C. A., Reis G., Kozma S. C., Thomas G., Schuman E. M., Rosenblum K. and Klann E. (2008b) Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity. Learn Mem 15, 2938.
  • Autry A. E., Adachi M., Nosyreva E., Na E. S., Los M. F., Cheng P. F., Kavalali E. T. and Monteggia L. M. (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 9195.
  • Banko J. L., Hou L., Poulin F., Sonenberg N. and Klann E. (2006) Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 26, 21672173.
  • Barch D. M. and Ceaser A. (2012) Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn Sci 16, 2734.
  • Bekinschtein P., Katche C., Slipczuk L. N., Igaz L. M., Cammarota M., Izquierdo I. and Medina J. H. (2007) mTOR signaling in the hippocampus is necessary for memory formation. Neurobiol. Learn. Mem. 87, 303307.
  • Beretta L., Gingras A. C., Svitkin Y. V., Hall M. N. and Sonenberg N. (1996) Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15, 658664.
  • Bock H. H., Jossin Y., Liu P., Forster E., May P., Goffinet A. M. and Herz J. (2003) Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J. Biol. Chem. 278, 3877238779.
  • Bradshaw N. J. and Porteous D. J. (2012) DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology 62, 12301241.
  • Burnett P. E., Barrow R. K., Cohen N. A., Snyder S. H. and Sabatini D. M. (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl Acad. Sci. USA 95, 14321437.
  • van den Buuse M. (2010) Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr. Bull. 36, 246270.
  • van den Buuse M., Halley P., Hill R., Labots M. and Martin S. (2012) Altered N-methyl-D-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 37, 237246.
  • Cammalleri M., Lutjens R., Berton F., King A. R., Simpson C., Francesconi W. and Sanna P. P. (2003) Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl Acad. Sci. USA 100, 1436814373.
  • Campbell D. S. and Holt C. E. (2001) Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 32, 10131026.
  • Catts V. S., Fung S. J., Long L. E. et al. (2013) Rethinking schizophrenia in the context of normal neurodevelopment. Front Cell Neurosci. 7, 60.
  • Cook S. C. and Wellman C. L. (2004) Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J. Neurobiol. 60, 236248.
  • Cracco J. B., Serrano P., Moskowitz S. I., Bergold P. J. and Sacktor T. C. (2005) Protein synthesis-dependent LTP in isolated dendrites of CA1 pyramidal cells. Hippocampus 15, 551556.
  • Folsom T. D. and Fatemi S. H. (2013) The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 68, 122135.
  • Gong R., Park C. S., Abbassi N. R. and Tang S. J. (2006) Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J. Biol. Chem. 281, 1880218815.
  • Graber T. E., McCamphill P. K. and Sossin W. S. (2013) A recollection of mTOR signaling in learning and memory. Learn Mem. 20, 518530.
  • Green A. I., Noordsy D. L., Brunette M. F. and O'Keefe C. (2008) Substance abuse and schizophrenia: pharmacotherapeutic intervention. J. Subst. Abuse Treat. 34, 6171.
  • Grider M. H., Park D., Spencer D. M. and Shine H. D. (2009) Lipid raft-targeted Akt promotes axonal branching and growth cone expansion via mTOR and Rac1, respectively. J. Neurosci. Res. 87, 30333042.
  • Hill R. A., Wu Y. W., Gogos A. and van den Buuse M. (2013) Sex-dependent alterations in BDNF-TrkB signaling in the hippocampus of reelin heterozygous mice: a role for sex steroid hormones. J. Neurochem. 126, 389399.
  • Holt D. J., Lebron-Milad K., Milad M. R., Rauch S. L., Pitman R. K., Orr S. P., Cassidy B. S., Walsh J. P. and Goff D. C. (2009) Extinction memory is impaired in schizophrenia. Biol. Psychiatry 65, 455463.
  • Hou L. and Klann E. (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 24, 63526361.
  • Huang E. P. (1998) Synaptic plasticity: going through phases with LTP. Curr. Biol. 8, R350R352.
  • Huang W., Zhu P. J., Zhang S., Zhou H., Stoica L., Galiano M., Krnjevic K., Roman G. and Costa-Mattioli M. (2013) mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat. Neurosci. 16, 441448.
  • Humphrey S. J., Yang G., Yang P., Fazakerley D. J., Stockli J., Yang J. Y. and James D. E. (2013) Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metab. 17, 10091020.
  • Iafrati J., Orejarena M. J., Lassalle O., Bouamrane L. and Chavis P. (2013) Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway. Mol. Psychiatry. 19, 417426.
  • Inamura N., Nawa H. and Takei N. (2005) Enhancement of translation elongation in neurons by brain-derived neurotrophic factor: implications for mammalian target of rapamycin signaling. J. Neurochem. 95, 14381445.
  • Issa G., Wilson C., Terry A. V., Jr and Pillai A. (2010) An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiol. Dis. 39, 327333.
  • Jaaro-Peled H. (2009) Gene models of schizophrenia: DISC1 mouse models. Prog. Brain Res. 179, 7586.
  • Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., Jung S. Y., Huang Q., Qin J. and Su B. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125137.
  • Jan Y. N. and Jan L. Y. (2003) The control of dendrite development. Neuron 40, 229242.
  • Jaworski J., Spangler S., Seeburg D. P., Hoogenraad C. C. and Sheng M. (2005) Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway. J. Neurosci. 25, 1130011312.
  • Jefferies H. B., Fumagalli S., Dennis P. B., Reinhard C., Pearson R. B. and Thomas G. (1997) Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k. EMBO J. 16, 36933704.
  • Jossin Y. and Goffinet A. M. (2007) Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth. Mol. Cell. Biol. 27, 71137124.
  • Kauderer B. S. and Kandel E. R. (2000) Capture of a protein synthesis-dependent component of long-term depression. Proc. Natl Acad. Sci. USA 97, 1334213347.
  • Kim D. H., Sarbassov D. D., Ali S. M., Latek R. R., Guntur K. V., Erdjument-Bromage H., Tempst P. and Sabatini D. M. (2003) GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 11, 895904.
  • Kumar V., Zhang M. X., Swank M. W., Kunz J. and Wu G. Y. (2005) Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J. Neurosci. 25, 1128811299.
  • Leal G., Comprido D. and Duarte C. B. (2013) BDNF-induced local protein synthesis and synaptic plasticity. Neuropharmacology. 76, 639656.
  • LeDoux J. E. (2000) Emotion circuits in the brain. Annu. Rev. Neurosci. 23, 155184.
  • Liu Y., Wong T. P., Aarts M. et al. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 28462857.
  • Ma L., Chen Z., Erdjument-Bromage H., Tempst P. and Pandolfi P. P. (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179193.
  • Malenka R. C. (1994) Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78, 535538.
  • Marsman A., van den Heuvel M. P., Klomp D. W. J., Kahn R. S., Luijten P. R. and Hulshoff Pol H. E. (2013) Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr. Bull. 39, 120129.
  • Martin K. C. (2004) Local protein synthesis during axon guidance and synaptic plasticity. Curr. Opin. Neurobiol. 14, 305310.
  • Martin S. J., Grimwood P. D. and Morris R. G. (2000) Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 23, 649711.
  • McGrath J. J., Féron F. P., Burne T. H., Mackay-Sim A. and Eyles D. W. (2003) The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann. Med. 35, 8693.
  • Meffre J., Chaumont-Dubel S., Mannoury la Cour C. et al. (2012) 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Mol. Med. 4, 10431056.
  • Moghaddam B. and Javitt D. (2012) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37, 415.
  • Nestler E. J. (2012) Epigenetics: stress makes its molecular mark. Nature 490, 171172.
  • Nojima H., Tokunaga C., Eguchi S. et al. (2003) The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J. Biol. Chem. 278, 1546115464.
  • Norman R. M. G., Malla A. K., McLean T. S., McIntosh E. M., Neufeld R. W. J., Voruganti L. P. and Cortese L. (2002) An evaluation of a stress management program for individuals with schizophrenia. Schizophr. Res. 58, 293303.
  • Oshiro N., Yoshino K.-I., Hidayat S., Tokunaga C., Hara K., Eguchi S., Avruch J. and Yonezawa K. (2004) Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells 9, 359366.
  • Owen M. J., O'Donovan M. C., Thapar A. and Craddock N. (2011) Neurodevelopmental hypothesis of schizophrenia. Br. J. Psychiatry 198, 173175.
  • Parsons R. G., Gafford G. M. and Helmstetter F. J. (2006) Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons. J. Neurosci. 26, 1297712983.
  • Pearce L. R., Huang X., Boudeau J. et al. (2007) Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem. J. 405, 513522.
  • Pillai A. and Mahadik S. P. (2008) Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia. Schizophr. Res. 100, 325333.
  • Piper M., Anderson R., Dwivedy A., Weinl C., van Horck F., Leung K. M., Cogill E. and Holt C. (2006) Signaling mechanisms underlying Slit2-induced collapse of Xenopus retinal growth cones. Neuron 49, 215228.
  • Polman J. A., Hunter R. G., Speksnijder N., van den Oever J. M., Korobko O. B., McEwen B. S., de Kloet E. R. and Datson N. A. (2012) Glucocorticoids modulate the mTOR pathway in the hippocampus: differential effects depending on stress history. Endocrinology 153, 43174327.
  • Proud C. G. (2009) mTORC1 signalling and mRNA translation. Biochem. Soc. Trans. 37, 227231.
  • Roberts R. C. (2007) Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings. Schizophr. Bull. 33, 1115.
  • Rogers J. T., Zhao L., Trotter J. H. et al. (2013) Reelin supplementation recovers sensorimotor gating, synaptic plasticity and associative learning deficits in the heterozygous reeler mouse. J. Psychopharmacol. 27, 386395.
  • Rossé G. and Schaffhauser H. (2010) 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment. Curr. Top. Med. Chem. 10, 207221.
  • Sarbassov D. D., Ali S. M., Kim D. H., Guertin D. A., Latek R. R., Erdjument-Bromage H., Tempst P. and Sabatini D. M. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 12961302.
  • Sarbassov D. D., Ali S. M., Sengupta S., Sheen J. H., Hsu P. P., Bagley A. F., Markhard A. L. and Sabatini D. M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159168.
  • Savonenko A. V., Melnikova T., Laird F. M., Stewart K.-A., Price D. L. and Wong P. C. (2008) Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc. Natl Acad. Sci. USA 105, 55855590.
  • Schalm S. S. and Blenis J. (2002) Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12, 632639.
  • Schratt G. M., Nigh E. A., Chen W. G., Hu L. and Greenberg M. E. (2004) BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J. Neurosci. 24, 73667377.
  • Sehgal S. N. (1995) Rapamune (Sirolimus, Rapamycin): an Overview and Mechanism of Action. Ther. Drug Monit. 17, 660665.
  • Siuta M. A., Robertson S. D., Kocalis H. et al. (2010) Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol. 8, e1000393.
  • Slipczuk L., Bekinschtein P., Katche C., Cammarota M., Izquierdo I. and Medina J. H. (2009) BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS ONE 4, e6007.
  • Stoica L., Zhu P. J., Huang W., Zhou H., Kozma S. C. and Costa-Mattioli M. (2011) Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc. Natl Acad. Sci. USA 108, 37913796.
  • Suri D. and Vaidya V. A. (2013) Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity. Neuroscience 239, 196213.
  • Swiech L., Perycz M., Malik A. and Jaworski J. (2008) Role of mTOR in physiology and pathology of the nervous system. Biochim. Biophys. Acta 1784, 116132.
  • Takahashi T., Hara K., Inoue H., Kawa Y., Tokunaga C., Hidayat S., Yoshino K., Kuroda Y. and Yonezawa K. (2000) Carboxyl-terminal region conserved among phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo and in vitro. Genes Cells 5, 765775.
  • Tamura Y., Kunugi H., Ohashi J. and Hohjoh H. (2007) Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol. Psychiatry 12, 593600.
  • Tang S. J., Reis G., Kang H., Gingras A. C., Sonenberg N. and Schuman E. M. (2002) A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl Acad. Sci. USA 99, 467472.
  • Tavazoie S. F., Alvarez V. A., Ridenour D. A., Kwiatkowski D. J. and Sabatini B. L. (2005) Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 8, 17271734.
  • Tee A. R., Manning B. D., Roux P. P., Cantley L. C. and Blenis J. (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 12591268.
  • Thomanetz V., Angliker N., Cloetta D., Lustenberger R. M., Schweighauser M., Oliveri F., Suzuki N. and Ruegg M. A. (2013) Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. J. Cell Biol. 201, 293308.
  • Tuominen H. J., Tiihonen J. and Wahlbeck K. (2005) Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophr. Res. 72, 225234.
  • Urbanska M., Gozdz A., Swiech L. J. and Jaworski J. (2012) Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons. J. Biol. Chem. 287, 3024030256.
  • Vander Haar E., Lee S. I., Bandhakavi S., Griffin T. J. and Kim D. H. (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9, 316323.
  • Vickers C. A., Dickson K. S. and Wyllie D. J. (2005) Induction and maintenance of late-phase long-term potentiation in isolated dendrites of rat hippocampal CA1 pyramidal neurones. J. Physiol. 568, 803813.
  • Wang L., Harris T. E. and Lawrence J. C., Jr (2008) Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. J. Biol. Chem. 283, 1561915627.
  • Watanabe Y., Gould E. and McEwen B. S. (1992) Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res. 588, 341345.
  • Weiner I. (2003) The “two-headed” latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169, 257297.
  • Weston M. C., Chen H. and Swann J. W. (2012) Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission. J. Neurosci. 32, 1144111452.
  • Wu Y. C., Hill R. A., Klug M. and van den Buuse M. (2012) Sex-specific and region-specific changes in BDNF-TrkB signalling in the hippocampus of 5-HT1A receptor and BDNF single and double mutant mice. Brain Res. 1452, 1017.
  • Yang Q., Inoki K., Ikenoue T. and Guan K. L. (2006) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 20, 28202832.
  • Zhang Y., Gao X., Saucedo L. J., Ru B., Edgar B. A. and Pan D. (2003) Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5, 578581.
  • Zhang J. P., Lencz T., Geisler S., DeRosse P., Bromet E. J. and Malhotra A. K. (2013) Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia. Schizophr. Res. 146, 285288.
  • Zho W. M., You J. L., Huang C. C. and Hsu K. S. (2002) The group I metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine induces a novel form of depotentiation in the CA1 region of the hippocampus. J. Neurosci. 22, 88388849.
  • Zhou M., Li W., Huang S. et al. (2013) mTOR Inhibition ameliorates cognitive and affective deficits caused by Disc1 knockdown in adult-born dentate granule neurons. Neuron 77, 647654.
  • Ziv N. E. and Smith S. J. (1996) Evidence for a Role of Dendritic Filopodia in Synaptogenesis and Spine Formation. Neuron 17, 91102.